Related Experiment Video
Updated: May 13, 2025

Capturing the Interaction Kinetics of an Ion Channel Protein with Small Molecules by the Bio-layer Interferometry Assay
Published on: March 7, 2018
Amalgamation of experimental strategies, computational simulation, and computer-assisted-theoretical analysis to
Chitra Loganathan1,2, Saravanan Kandasamy3, Penislusshiyan Sakayanathan1
1Bioinnov Solutions LLP, Research and Development Center, Salem, India.
Abstract:
Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are important target proteins to treat cognitive dysfunction in neurodegenerative diseases, such as Alzheimer's disease and Parkinson disease. Hence identification of inhibitors against these proteins is ever-growing. To get a foresight on the potential of a molecule that could be forwarded as a drug candidate, the combinations of bioinformatics [including molecular docking and molecular dynamics (MD) simulation], computer-assisted-theoretical analysis and in vitro strategy were employed to gain knowledge on interaction/inhibition of newly synthesized ester of plumbagin (PLU) and indole-3-propionic acid (IPA) called PLU-IPA with/against AChE and BChE. Density functional theory and ADME analysis revealed the non-toxicity and chemical reactivity gained by the molecule due to esterification and drug-likeness of PLU-IPA. PLU-IPA inhibited AChE and BChE in micromolar concentration through non-competitive mode. In molecular docking, PLU-IPA interacted with amino acids present in sub-pockets near the catalytic site, anionic site, and PAS of electric eel AChE (eAChE), human AChE (hAChE), and hBChE. Through computer-assisted-theoretical analysis, the importance of non-covalent interactions for the proper orientation of PLU-IPA within the active site gorge of AChE/BChE was understood. Further MD simulation results also confirmed the stable interaction of PLU-IPA with AChE/BChE.
More Related Videos
07:22Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...